Jessica Chery

Jessica Chery

Dana Farber Cancer Center/Harvard Medical School • Pediatric Oncology/Cell Biology

Developing a gene editing approach for very early-onset inflammatory bowel disease (VEO-IBD)

Children have Inflammatory Bowel Disease (IBD)—called Very Early Onset IBD (VEO-IBD)—due to mutations in genes that regulate inflammation. We are developing a gene editing approach to correct the VEO-IBD relevant mutations in patient stem cells, bypassing the risks associated with donor transplantations and making autologous stem cell transplantation a possible cure for this disease.

Leave a Reply

Your email address will not be published. Required fields are marked *